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even though prices have dropped considerably in the
past few years. Trained practice staff who have the skills
and time to fit and maintain spirometry of sufficient
quality into the daily practice routine9 may also be in
short supply.10 In addition to the practical issues, GPs’
lack of confidence in their ability to interpret the test
results is a crucial barrier—often neglected in the
guidelines to effective implementation of spirometry.8
Many GPs view spirometry as a complex diagnostic
tool, like electrocardiography. This fact was clearly
illustrated in a recent UK study that reported low levels
of self confidence in interpreting spirometric tests in
160 general practices where GPs and nurses had been
trained for half a day—only a third of these profession-
als trusted their own interpretative skills.8 Confidence
about how to proceed once the test results are available
is a crucial part of building GPs’ confidence in their
capacity to diagnose and manage the disease.
Ideally once GPs have had initial spirometry train-
ing they should receive continuous advice and support.
This could be done in various ways—by another GP
with a special interest in respiratory diseases in the
same practice or in another practice nearby; by means
of a computerised clinical decision support system
(SpidaXpert software; www.spirxpert.com); or by
consultation or feedback from a chest physician.
Although intuitively a promising idea, empirical
studies on the effects of ongoing expert support on the
interpretative capacity and self confidence of GPs are
lacking.
So what needs to happen next? For guidelines on
chronic obstructive pulmonary disease to be imple-
mented, concrete working agreements between GPs
and chest physicians need to be developed. Chest phy-
sicians can act as coaches for their local primary care
colleagues in two ways—through patient oriented sup-
port (specific feedback for specific patients) or through
practice oriented support (as teachers in postgraduate
training programmes). This will be beneficial for both
parties, as referrals will be more structured and based
on agreed criteria, GPs who have performed
spirometry will have better insight into the patient’s
lung function, and chest physicians will benefit from
having the results at the initial consultation.11 More
broadly, coordinated efforts by health policy makers
and the medical profession will be needed to provide
the right equipment, training for staff who use it, and
continuing quality assurance and support for test
interpretation. The burden of chronic obstructive pul-
monary disease is sufficiently large to warrant such an
approach.
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A European alcohol strategy
Will the opportunity be missed?
This month the European Commission mustdecide whether to adopt a strategy to deal withthe adverse health consequences of alcohol.
The strategy has been awaited eagerly by Europe’s
public health community since it was first mooted five
years ago, but it could fall at the last hurdle. It may be
the victim of a carefully planned attack by representa-
tives of the alcohol industry, using tactics associated
with tobacco manufacturers.
Alcohol related disease accounts for almost 8% of
the overall burden of disease in Europe.1 One factor
contributing to the current level of consumption is the
single European market, testified to by the existence of
vast retail outlets around Calais that thousands of Brit-
ish travellers visit each week. Yet the single market has
implications that go far beyond this type of cross
border trade. Countries such as Sweden and Finland
had longstanding stringent controls on alcohol sales
that restricted access to low cost alcohol. After they
joined the European Union in 1995 they had to
dismantle important parts of their policies,2 and over
the next decade death rates from cirrhosis in Finland
rose by 50%.3 The industry has also used the single
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market to justify attacks on labels being introduced in
France to warn pregnant women of the hazards of
drinking.4 Consequently, national health ministries
widely recognise the need for European support to
tackle the growing threat to health posed by the liber-
alisation of the alcohol sector, and in June 2001 they
asked the commission to prepare a comprehensive
strategy to reduce alcohol related harm.5
The directorate general of the European Commis-
sion responsible for public health began by commis-
sioning a thorough assessment of the health impact of
alcohol in Europe. The resulting report catalogued the
adverse effects on health in detail and showed how
alcohol attributable disease, injury, and violence cost
the health, welfare, employment, and criminal justice
sectors £84bn (€125bn; $157bn) each year, including
£40bn in lost production, while the intangible costs of
suffering and lost life added a further £182bn each
year.6
The draft strategy that emerged is now being
considered by all the commissioners and a decision on
whether to adopt it is expected at the end of October.
Although it is not yet in the public domain, its key fea-
tures can be ascertained from the consultation that
informed it. It is expected to have five main themes.
These are protection of young people and unborn
children; reduction of deaths from alcohol related traf-
fic accidents; reduction of alcohol related harm among
adults, especially as it affects their work; increasing
awareness of the impact of harmful consumption; and
the creation of a better evidence base for future
policies on alcohol in Europe.
The strategy foresees several actions at the
European level, such as monitoring drinking habits
among young people as well as ensuring that alcohol
related harm is taken into account in sectors where the
European Union can legislate, such as cross border
advertising, road safety, and consumer information. It
also envisages support for comparative research and
data collection across Europe. However, its main thrust
will be to support collaboration among member states,
encouraging them to implement policies that are
evidence based and proportionate.
Given the magnitude of the threat to health posed
by hazardous drinking, some may argue that the strat-
egy should go much further.5 Nevertheless, the key
issue is that the scope for European action on public
health is limited by the treaties that establish the EU’s
legislative powers.
Unfortunately, even these modest proposals may
now fail. Emerging evidence indicates that some
elements of the alcohol industry have been engaged in
a massive and highly effective exercise to derail them.7
Their approach is exemplified by a report commis-
sioned by the trade organisation, The Brewers of
Europe, which argues that there is no need for Europe
wide action.8 It was written by the Weinberg Group, an
American company previously involved in the tobacco
industry’s campaign to undermine evidence on the
harmful effects of passive smoking9 and those by the
chemical industry to challenge evidence on the harm-
ful environmental effects of substances such as agent
orange.10 Its content is remarkably similar to the
tobacco industry reports that contended there was
insufficient evidence that its products caused any harm
or that preventive measures would be effective. For
example, it concludes that “there is not enough
evidence to substantiate a link between alcohol adver-
tising and consumption,” which raises the question of
why the industry spends so much money promoting its
products, and that “violence is a subjective term which
is fairly nebulous and elastic,” a view unlikely to be
shared by those scarred by bottles wielded by drunks.
Now that the methods used by the tobacco industry
have been exposed, few serious commentators believe
what they say. Unfortunately, the alcohol industry
seems to be going down the same path. European
commissioners will miss a valuable opportunity to
improve the health of their fellow citizens if they are
taken in by the alcohol industry’s arguments.
Martin McKee professor of European public health
(martin.mckee@lshtm.ac.uk)
London School of Hygiene and Tropical Medicine, London
WC1E 7HT
Competing interests: MM’s work on the tobacco industry, which
informed this editorial, is funded by the US National Institutes
of Health, grant CA 91021-01.
1 Rehm J, Room R, Monteiro M, Gmel K, Graham N, Rehn C, et al. Alco-
hol. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, eds. Comparative
quantification of health risks: global and regional burden of disease due to
selected major risk factors. Geneva: World Health Organization,
2004:959-1108.
2 Gilmore AB, Österberg E, Heloma A, Zatonski W, Delcheva E, McKee M.
Free trade versus the protection of health: the examples of alcohol and
tobacco. In: McKee M, MacLehose L, Nolte E, eds. Health policy and Euro-
pean Union enlargement. Buckingham: Open University Press, 2004:198-
224.
3 World Health Organization. Health for all database. Copenhagen: WHO,
2006. http://data.euro.who.int/hfadb/ (accessed 13 Oct 2006).
4 European Spirits News, July 2006. www.europeanspirits.org/documents/
european_spirits_news_-_july_2006_en.pdf (accessed 9 Oct 2006).
5 Council of Ministers of the European Union. Council conclusion
2001/C175/01 on a Community strategy to reduce alcohol-related harm.
http://www.eurocare.org/pdf/eu/01_c175.pdf (accessed 13 Oct 2006).
6 Anderson P, Baumberg B.Alcohol in Europe:a public health perspective. Lon-
don: Institute of Alcohol Studies, 2006.
7 Taylor S. Alcohol strategy attacked on two fronts. EuropeanVoice.com 14
Sep 2006.
8 The Weinberg Group. An independent review of issues related to alcohol con-
sumption in Europe. Brussels: Weinberg Group, 2006.
9 Ong EK, Glantz SA. Tobacco industry efforts subverting International
Agency for Research on Cancer’s second hand smoke study. Lancet
2000;355:1253-9.
10 Thacker PD. The Weinberg proposal: a scientific consulting firm says that
it aids companies in trouble, but critics say that it manufactures
uncertainty and undermines science. Environ Sci Technol 21 Feb 2006.
http://pubs.acs.org/subscribe/journals/esthag-w/2006/feb/business/
pt_weinberg.html (accessed 8 Oct 2006).
doi 10.1136/bmj.39003.629606.BE
Editorials
872 BMJ VOLUME 333 28 OCTOBER 2006 bmj.com
